PE20010705A1 - Uso de secrecion apo b/inhibidores mtp - Google Patents
Uso de secrecion apo b/inhibidores mtpInfo
- Publication number
- PE20010705A1 PE20010705A1 PE2000001207A PE0012072000A PE20010705A1 PE 20010705 A1 PE20010705 A1 PE 20010705A1 PE 2000001207 A PE2000001207 A PE 2000001207A PE 0012072000 A PE0012072000 A PE 0012072000A PE 20010705 A1 PE20010705 A1 PE 20010705A1
- Authority
- PE
- Peru
- Prior art keywords
- butyl
- isoindol
- fluorene
- carboxamide
- piperidinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE APOLIPOPROTEINA B/INHIBIDOR DE PROTEINAS DE TRANSFERENCIA DE TRIGLICERIDOS MICROSOMICOS TAL COMO i)UN COMPUESTO DE FORMULA I DONDE L ES X-Y-Z; X ES CH2, CO, CS, SO2; Y ES UN ENLACE, HIDROCARBILENOS ALIFATICOS; Z ES H, HALOGENO, CIANO, OH, ALCOXI C1-C10, ACILO C1-C10, ALQUILAMINO C1-C10, VINILO, ARILOXI C6-C10, HETEROCICLILO, ENTRE OTROS; SIEMPRE QUE X ES CH2, Y ES UN ENLACE; SON COMPUESTOS PREFERIDOS 4`-TRIFLUOROMETIL-BIFENIL-2-ACIDO CARBOXILICO-(2-BUTIL-1,2,3,4-TETRAHIDROISOQUINOLIN-6-IL)AMIDA, 4'-TRIFLUOROMETIL-BIFENIL-2-ACIDO CARBOXILICO-[2-(2-ACETILAMINOETIL)-1,2,3,4-TETRAHIDROISOQUINOLIN-6-IL AMIDA, 9-[4-[4-(2,3-DIHIDRO-1-OXO-1H-ISOINDOL-2-IL)-1-PIPERIDINIL]BUTIL]-N-PROPIL-9H-FLUORENO-9-CARBOXAMIDA; 2-[1-(3,3-DIFENILPROPIL)-4-PIPERIDINIL]-2,3-DIHIDRO-1H-ISOINDOL-1-ONA; 9-[4-(4-[2-(4-TRIFLUOROMETILFENIL)BENZOILAMINO]PIPERIDIN-1-IL)BUTIL]-N-2,2,2-TRIFLUOROETIL)-9H-FLUORENO-9-CARBOXAMIDA; b)9-[4-[4-(2,3-DIHIDRO-1-OXO-1H-ISOINDOL-2-IL)-1-IL)-1-PIPERIDINIL]-BUTIL]-N-PROPIL-9H-FLUORENO-9-CARBOXAMIDA Y UN AGENTE ANTIOBESIDAD TAL COMO SIBUTRAMINA, ORLISTAT, FENFLURAMINA, DEXFENFLURAMINA, BROMOCRIPTINA, FENTERMINA, EFEDRINA, LEPTINA, FENILPROPANOLAMINA, PSEUDOEFEDRINA, ENTRE OTROS. LA COMPOSICION PUEDE SER UTIL PARA REDUCIR LA ABSORCION DE GRASA INTESTINAL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16454799P | 1999-11-10 | 1999-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010705A1 true PE20010705A1 (es) | 2001-07-11 |
Family
ID=22595001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001207A PE20010705A1 (es) | 1999-11-10 | 2000-11-10 | Uso de secrecion apo b/inhibidores mtp |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1099439A3 (es) |
JP (1) | JP2001172180A (es) |
KR (1) | KR20010051558A (es) |
AU (1) | AU6968700A (es) |
CA (1) | CA2324800A1 (es) |
CO (1) | CO5261534A1 (es) |
HU (1) | HUP0004461A3 (es) |
IL (1) | IL139448A0 (es) |
NZ (1) | NZ508059A (es) |
PE (1) | PE20010705A1 (es) |
ZA (1) | ZA200006419B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101838218A (zh) | 2002-02-28 | 2010-09-22 | 日本烟草产业株式会社 | 酯化合物及其医药用途 |
US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
JP4832897B2 (ja) | 2003-08-29 | 2011-12-07 | 日本たばこ産業株式会社 | エステル誘導体及びその医薬用途 |
US20060084636A1 (en) * | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
KR101129456B1 (ko) * | 2004-10-25 | 2012-03-28 | 니뽄 다바코 산교 가부시키가이샤 | 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법 |
KR20070072888A (ko) * | 2004-10-25 | 2007-07-06 | 니뽄 다바코 산교 가부시키가이샤 | 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법 |
US9035059B2 (en) * | 2011-03-14 | 2015-05-19 | Taisho Pharmaceutical Co., Ltd. | Nitrogen-containing condensed heterocyclic compound |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU218419B (hu) * | 1992-03-06 | 2000-08-28 | E.R. Squibb And Sons, Inc. | Mikroszomális triglicerid transzfer protein (MTP) nagy molekulatömegű alegységének rekombináns úton történő előállítására és a protein és inhibitorainak kimutatására szolgáló eljárások |
US5474993A (en) * | 1994-06-14 | 1995-12-12 | Sterling Winthrop, Inc. | Lactam inhibitors of cholesterol esterase |
EP0832069B1 (en) * | 1995-06-07 | 2003-03-05 | Pfizer Inc. | BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
ATE223400T1 (de) * | 1996-04-30 | 2002-09-15 | Pfizer | Verfahren und zwischenprodukte zur herstellung von 4-trifluoromethylbiphenyl-2-carbonsaüre,(2- (2h-(1,2,4) triazol-3-ylmethyl)-1,2,3,4- tetrahydro-isoquinolin-6-yl)-amide |
KR100334567B1 (ko) * | 1996-11-27 | 2002-05-03 | 디. 제이. 우드, 스피겔 알렌 제이 | 아포 비-분비/엠티피 억제성 아미드 |
US5968950A (en) * | 1997-06-23 | 1999-10-19 | Pfizer Inc | Apo B-secretion/MTP inhibitor hydrochloride salt |
IL133201A0 (en) * | 1998-12-04 | 2001-03-19 | Pfizer Prod Inc | Lowering blood levels of lipoproten (a) |
-
2000
- 2000-10-31 CA CA002324800A patent/CA2324800A1/en not_active Abandoned
- 2000-11-02 IL IL13944800A patent/IL139448A0/xx unknown
- 2000-11-02 AU AU69687/00A patent/AU6968700A/en not_active Abandoned
- 2000-11-03 EP EP00309721A patent/EP1099439A3/en not_active Withdrawn
- 2000-11-08 ZA ZA200006419A patent/ZA200006419B/xx unknown
- 2000-11-09 NZ NZ508059A patent/NZ508059A/xx unknown
- 2000-11-09 HU HU0004461A patent/HUP0004461A3/hu unknown
- 2000-11-09 KR KR1020000066367A patent/KR20010051558A/ko not_active Application Discontinuation
- 2000-11-10 PE PE2000001207A patent/PE20010705A1/es not_active Application Discontinuation
- 2000-11-10 CO CO00085765A patent/CO5261534A1/es not_active Application Discontinuation
- 2000-11-10 JP JP2000342892A patent/JP2001172180A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CO5261534A1 (es) | 2003-03-31 |
CA2324800A1 (en) | 2001-05-10 |
EP1099439A2 (en) | 2001-05-16 |
EP1099439A3 (en) | 2003-03-26 |
NZ508059A (en) | 2002-11-26 |
JP2001172180A (ja) | 2001-06-26 |
HUP0004461A2 (hu) | 2001-10-28 |
AU6968700A (en) | 2001-05-17 |
HUP0004461A3 (en) | 2004-04-28 |
IL139448A0 (en) | 2001-11-25 |
KR20010051558A (ko) | 2001-06-25 |
HU0004461D0 (es) | 2001-01-29 |
ZA200006419B (en) | 2002-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5261539A1 (es) | Compuestos farmaceuticamente activos | |
PE20001646A1 (es) | BIFENILO QUE CONTIENEN COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE aP2 | |
PE20040608A1 (es) | Compuestos de alquino con efecto antagonico de la hcm y medicamentos que los contienen | |
MA27265A1 (fr) | Formulations d'agoniste opioide a antagoniste liberable et sequestre | |
PE20001600A1 (es) | Derivados de 1,4-diazabiciclo (3.3.2) nonan-4-carboxilatos y carboxamidas, su preparacion y su aplicacion en terapeutica | |
PE20010705A1 (es) | Uso de secrecion apo b/inhibidores mtp | |
AR009278A1 (es) | 7alfa-(xi-aminoalquil)-estratrienos sustituidos, preparados farmaceuticos que los contienen y el empleo de los mismos para preparar medicamentos | |
ES2054725T3 (es) | Heteroaromatos anulares de cinco miembros de p-fenoxi-fenoximetilo. | |
CO5271666A1 (es) | Derivados de pirimidina | |
DE69735442D1 (de) | Antidiabetische mittel | |
PE16299A1 (es) | Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoreceptores | |
PE29798A1 (es) | Acetidinas | |
ATE13055T1 (de) | Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung. | |
ES2059416T3 (es) | 1,4-dihidropiridina-enantiomeros. | |
DK359387A (da) | Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling | |
ES2062425T3 (es) | Piridinas, procedimientos de preparacion y medicamentos que las contienen. | |
PT92647A (pt) | Processo para a preparacao de 5-cloro-2-< { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem | |
ES2059688T3 (es) | Derivados de aminoacidos inhibidores de enzimas, procedimiento para su preparacion, agentes que los contienen y su utilizacion. | |
AR025638A1 (es) | Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles | |
CY1105373T1 (el) | Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα | |
DK306384A (da) | Fremgangsmaade til reduktion af biproduktbestanddele ved fremstillingen af carbendazim | |
CO5210926A1 (es) | Mezclas fungicidas | |
AR009452A1 (es) | Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos. | |
DE69717969D1 (de) | Substituierte n-methyl-n-(4-(piperidin-1-yl)-2-arylbutyl)-benzamide zur behandlung von allergischen erkrankungen | |
DK520787A (da) | Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |